Open Save New
FeedNavigator / National Library of Health Sciences
Tutkijat / Kuopio
AddAiraksinen, O(lavi)
AddAlhava, E.
AddAlhonen, L.
AddAtalay, M(ustafa)
AddCederberg, H.
AddDunkel, L(eo)
AddEskelinen, M(atti)
AddGiniatullin, R.
AddGröhn, O(lli)
AddHarno, K.
AddHartikainen, J(aana).
AddHartikainen, J(uha).
AddHarvima, I.
AddHiltunen, M(ikko)
AddJääskeläinen, J(uha) E.
AddJäkälä, P(ekka)
AddJänne, J.
AddJantunen, E(sa)
AddJärvinen, R.
AddJulkunen, P.
AddKaikkonen, M(inna) U.
AddKauhanen, J(ussi)
AddKivipelto, M(iia)
AddKoistinaho, M.
AddKoivisto, T(imo)
AddKokki, H.
AddKönönen, M.
AddKosma, V(eli)-M(atti)
AddKröger, H.
AddKurl, S(udhir)
AddKuusisto, J(ohanna)
AddLaakso, M(arkku)
AddLakka, T(imo) A.
AddLapinlampi, N(iina)
AddLaukkanen, J(ari) (UEF/KSSHP)
AddLevonen, A(nna)-L(iisa)
AddLindgren, A(ntti) E.
AddLöppönen, H(eikki)
AddMannermaa, A.
AddManninen, H.
AddMecklin, J(ukka)-P(ekka)
AddMoilanen, L(eena)
AddMönkkönen, J.
AddMykkänen, H.
AddNuutinen, J.
AddPaajanen, H.
AddPaananen, J.
AddPalvimo, J.J.
AddPelkonen, J(ukka)
AddPihlajamäki, J(ussi)
AddPihlajamäki, M.
AddPitkänen, A(sla)
AddPunnonen, K.
AddRaatikainen K
AddRauramaa, R.
AddRissanen, T.T.
AddRoine, R(isto) P.
AddRyynänen, O.P.
AddSaarikoski, S.
AddSchwab, U(rsula)
AddSivenius, J.
AddSoininen, H(ilkka)
AddSoininen, P(asi)
AddSorri, I.
AddStancakova, A(lena)
AddSulkava, R.
AddSund, R(eijo)
AddTammi, M.
AddTanila, H(eikki)
AddTiihonen, J(ari)
AddUusaro, A.
AddUusitupa, M.
AddVanninen, R.
AddVaskilampi, T.
AddViinamäki, H(eimo)
AddVirtanen, M(arianna)
AddVoutilainen, R(aimo)
AddVoutilainen, S(ari)
AddWahlfors, J.
AddWirth, T.
AddWong, G.
AddYlä-Herttuala, S(eppo)

Scholar Chart >>

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.Jantunen, E(sa)667 dayssaveRefWorks
Febrile neutropenia in patients with acute myeloid leukemia: outcome in relation to qSOFA score, C-reactive protein and blood culture findings.Jantunen, E(sa)784 dayssaveRefWorks
Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival.Jantunen, E(sa)804 dayssaveRefWorks
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma.Jantunen, E(sa)823 dayssaveRefWorks
Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas.Jantunen, E(sa)825 dayssaveRefWorks
Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study.Jantunen, E(sa)860 dayssaveRefWorks
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter Goa study.Jantunen, E(sa)883 dayssaveRefWorks
A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34+ cells in NHL patients.Jantunen, E(sa)888 dayssaveRefWorks
Plasma level of interleukin-18 and complicated course of febrile neutropenia in hematological patients after intensive chemotherapy.Jantunen, E(sa)946 dayssaveRefWorks
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT).Jantunen, E(sa)962 dayssaveRefWorks
Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry.Jantunen, E(sa)1012 dayssaveRefWorks
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.Jantunen, E(sa)1060 dayssaveRefWorks
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor.Jantunen, E(sa)1090 dayssaveRefWorks
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantatJantunen, E(sa)1100 dayssaveRefWorks
Incidence of solid cancer in patients with follicular lymphoma.Jantunen, E(sa)1151 dayssaveRefWorks
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.Jantunen, E(sa)1180 dayssaveRefWorks
MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia.Jantunen, E(sa)1216 dayssaveRefWorks
Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients.Jantunen, E(sa)1298 dayssaveRefWorks
Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.Jantunen, E(sa)1320 dayssaveRefWorks
Treatment of Diffuse Large B-cell Lymphoma in Elderly Patients; Replacing Doxorubicin with either Epirubicin or Etoposide (VP-16).Jantunen, E(sa)1368 dayssaveRefWorks
Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients.Jantunen, E(sa)1406 dayssaveRefWorks
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP.Jantunen, E(sa)1451 dayssaveRefWorks
Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study.Jantunen, E(sa)1487 dayssaveRefWorks
Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients.Jantunen, E(sa)1504 dayssaveRefWorks
Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.Jantunen, E(sa)1577 dayssaveRefWorks
Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.Jantunen, E(sa)1724 dayssaveRefWorks
Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.Jantunen, E(sa)1752 dayssaveRefWorks
Biomarkers of neutropenic sepsis.Jantunen, E(sa)1759 dayssaveRefWorks
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing.Jantunen, E(sa)1835 dayssaveRefWorks
Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly.Jantunen, E(sa)1843 dayssaveRefWorks
Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.Jantunen, E(sa)1843 dayssaveRefWorks
Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.Jantunen, E(sa)1854 dayssaveRefWorks
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood aJantunen, E(sa)1871 dayssaveRefWorks
Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.Jantunen, E(sa)1906 dayssaveRefWorks
Impact of lenalidomide-based induction therapy on the mobilization of CD34(+) cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.Jantunen, E(sa)1907 dayssaveRefWorks
Identification of precision treatment strategies for relapsed/ refractory multiple myeloma by functional drug sensitivity testing.Jantunen, E(sa)1955 dayssaveRefWorks
A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.Jantunen, E(sa)1959 dayssaveRefWorks
Old enemies in new disguises: emergence of Enterococcus faecium as a significant clinical problem at an adult haematology ward.Jantunen, E(sa)2026 dayssaveRefWorks
Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.Jantunen, E(sa)2042 dayssaveRefWorks
Pre-emptive plerixafor injection in lymphoma patients mobilized with chemotherapy plus pegfilgrastim followed by apheresis on the same day.Jantunen, E(sa)2055 dayssaveRefWorks
Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).Jantunen, E(sa)2167 dayssaveRefWorks
Cost analysis of a randomized stem cell mobilization study in multiple myeloma.Jantunen, E(sa)2244 dayssaveRefWorks
Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma.Jantunen, E(sa)2279 dayssaveRefWorks
[Sarcoidosis-lymphoma syndrome].Jantunen, E(sa)2321 dayssaveRefWorks
Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.Jantunen, E(sa)2365 dayssaveRefWorks
Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance.Jantunen, E(sa)2446 dayssaveRefWorks
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.Jantunen, E(sa)2547 dayssaveRefWorks
Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.Jantunen, E(sa)2634 dayssaveRefWorks
Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.Jantunen, E(sa)2677 dayssaveRefWorks
High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index.Jantunen, E(sa)2701 dayssaveRefWorks
 XML / RSS feed
next »